Annual Accounts Receivable
$265.00 K
-$15.00 K-5.36%
31 December 2023
Summary:
REGENXBIO annual accounts receivable is currently $265.00 thousand, with the most recent change of -$15.00 thousand (-5.36%) on 31 December 2023. During the last 3 years, it has fallen by -$30.31 million (-99.13%). RGNX annual accounts receivable is now -99.13% below its all-time high of $30.57 million, reached on 31 December 2020.RGNX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$5.05 M
-$35.00 K-0.69%
30 September 2024
Summary:
REGENXBIO quarterly accounts receivable is currently $5.05 million, with the most recent change of -$35.00 thousand (-0.69%) on 30 September 2024. Over the past year, it has increased by +$4.96 million (+5385.87%). RGNX quarterly accounts receivable is now -88.66% below its all-time high of $44.52 million, reached on 31 March 2020.RGNX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -5.4% | +5385.9% |
3 y3 years | -99.1% | -83.3% |
5 y5 years | -96.9% | -73.7% |
RGNX Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -99.1% | at low | -83.3% | +5385.9% |
5 y | 5 years | -99.1% | at low | -88.7% | +5385.9% |
alltime | all time | -99.1% | +430.0% | -88.7% | +9994.0% |
REGENXBIO Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $5.05 M(-0.7%) |
June 2024 | - | $5.08 M(+5.8%) |
Mar 2024 | - | $4.80 M(+1712.5%) |
Dec 2023 | $265.00 K(-5.4%) | $265.00 K(+188.0%) |
Sept 2023 | - | $92.00 K(-76.6%) |
June 2023 | - | $393.00 K(+57.2%) |
Mar 2023 | - | $250.00 K(-10.7%) |
Dec 2022 | $280.00 K(-23.3%) | $280.00 K(+86.7%) |
Sept 2022 | - | $150.00 K(-96.3%) |
June 2022 | - | $4.03 M(+815.5%) |
Mar 2022 | - | $440.00 K(+20.5%) |
Dec 2021 | $365.00 K(-98.8%) | $365.00 K(-98.8%) |
Sept 2021 | - | $30.25 M(+0.3%) |
June 2021 | - | $30.16 M(-1.4%) |
Mar 2021 | - | $30.58 M(+0.0%) |
Dec 2020 | $30.57 M(+8031.1%) | $30.57 M(+1.6%) |
Sept 2020 | - | $30.09 M(-29.8%) |
June 2020 | - | $42.88 M(-3.7%) |
Mar 2020 | - | $44.52 M(>+9900.0%) |
Dec 2019 | $376.00 K | $376.00 K(-98.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2019 | - | $19.18 M(+98.1%) |
June 2019 | - | $9.68 M(+15.6%) |
Mar 2019 | - | $8.37 M(-2.5%) |
Dec 2018 | $8.59 M(+1715.4%) | $8.59 M(+227.0%) |
Sept 2018 | - | $2.63 M(+255.3%) |
June 2018 | - | $739.00 K(-97.2%) |
Mar 2018 | - | $25.98 M(+5391.8%) |
Dec 2017 | $473.00 K(-54.2%) | $473.00 K(-46.5%) |
Sept 2017 | - | $884.00 K(+1668.0%) |
June 2017 | - | $50.00 K(-78.1%) |
Mar 2017 | - | $228.00 K(-77.9%) |
Dec 2016 | $1.03 M(-51.7%) | $1.03 M(+52.0%) |
Sept 2016 | - | $679.00 K(-13.3%) |
June 2016 | - | $783.00 K(-61.5%) |
Mar 2016 | - | $2.04 M(-4.7%) |
Dec 2015 | $2.14 M(+165.3%) | $2.14 M(+250.7%) |
Sept 2015 | - | $609.00 K(-13.5%) |
June 2015 | - | $704.00 K(-12.5%) |
Dec 2014 | $805.00 K(+1510.0%) | $805.00 K |
Dec 2013 | $50.00 K | - |
FAQ
- What is REGENXBIO annual accounts receivable?
- What is the all time high annual accounts receivable for REGENXBIO?
- What is REGENXBIO annual accounts receivable year-on-year change?
- What is REGENXBIO quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for REGENXBIO?
- What is REGENXBIO quarterly accounts receivable year-on-year change?
What is REGENXBIO annual accounts receivable?
The current annual accounts receivable of RGNX is $265.00 K
What is the all time high annual accounts receivable for REGENXBIO?
REGENXBIO all-time high annual accounts receivable is $30.57 M
What is REGENXBIO annual accounts receivable year-on-year change?
Over the past year, RGNX annual accounts receivable has changed by -$15.00 K (-5.36%)
What is REGENXBIO quarterly accounts receivable?
The current quarterly accounts receivable of RGNX is $5.05 M
What is the all time high quarterly accounts receivable for REGENXBIO?
REGENXBIO all-time high quarterly accounts receivable is $44.52 M
What is REGENXBIO quarterly accounts receivable year-on-year change?
Over the past year, RGNX quarterly accounts receivable has changed by +$4.96 M (+5385.87%)